Gunzburg reported on the properties of the nasal vaccine for the unvaccinated by Sputnik

Alexander Gunzburg

The nasal vaccine, developed by the Gamaleya Research Center for Epidemiology and Microbiology, will also protect those who have not previously been vaccinated with Sputnik V. About this "RIA Novosti" said the director of the center Alexander Gintsburg.

“For sure it will be if a person has been vaccinated with working vaccines that give antibodies,” Gunzburg said, answering a related question.

Gunzburg says nasal COVID vaccine has no side effects Society

In October, the Ministry of Health authorized the use of the nasal form of the vaccine, which is the second component of Sputnik V, for volunteers during the second phase of testing a new form of the drug. The research will last until December 2023 and will involve 500 volunteers.

As Gunzburg pointed out, the COVID-19 nasal vaccine has no side effects. At the same time, he noted that an additionally vaccinated with a nasal vaccine would not be a distributor of coronavirus.

See also Ukrainian border guards did not let foreigners vaccinated by Sputnik V 06:15

To date, six vaccines against coronavirus have been registered in Russia. These are "Sputnik M" for teenagers from 12 to 17 years old, "Sputnik V" and "Sputnik Light" of the Center. Gamaleya, "EpiVakKorona" and "EpiVakKorona-N" of the "Vector" center, as well as "KoviVak" of the Center. Chumakov.

According to the operational headquarters, as of November 26, 69.5 million people were vaccinated with the first dose of one of the coronavirus vaccines in Russia, and 60.8 million with two. The level of herd immunity was 51.8%.

How the number of deaths from Covid-19 in Russia is changing November 29 Daily data from the operational headquarters Created with Highcharts 8.2.2RussiaMoscowSt.
Jan 2020
2021Nov.0200400600800100012001400 Source: federal and regional headquarters for combating coronavirus Data for Russia i